Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol

被引：0
|
作者：
Ditte Hansen
Lisbet Brandi
Knud Rasmussen
机构：
[1] Roskilde Hospital,Medical Department
[2] University of Copenhagen,Department of Surgery and Internal Medicine
来源：
BMC Nephrology | / 10卷
关键词：
Chronic Kidney Disease; Hypercalcemia; Vascular Calcification; Secondary Hyperparathyroidism; Alfacalcidol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] ORAL CALCITRIOL VERSUS ORAL ALFACALCIDOL FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS RECEIVING HEMODIALYSIS: A RANDOMIZED, CROSSOVER TRIAL
    Moe, Samantha
    Wazny, Lori D.
    Martin, Janet E.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2008, 15 (01): : E36 - E43
  • [32] Paricalcitol (Zemplar®) injection for the treatment of secondary hyperparathyroidism in pediatric hemodialysis patients.
    Kommala, DR
    Benador, N
    Goldstein, S
    Pardes, A
    Mattingly, S
    Amdahl, M
    Greenbaum, L
    Williams, LA
    Salusky, I
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 199A - 199A
  • [33] COMPARISON OF INTRAVENOUS AND ORAL ALFACALCIDOL IN THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN HEMODIALYSIS-PATIENTS
    LEE, WT
    COLLINS, JF
    CUNDY, T
    KIDNEY INTERNATIONAL, 1992, 42 (04) : 1035 - 1035
  • [34] Efficacy of calcitriol compared to alfacalcidol for the treatment of secondary hyperparathyroidism in peritoneal dialysis patients
    Bezzaoucha, Sarah
    Lafrance, Jean-Philippe
    Ouimet, Denis
    Pichette, Vincent
    Bell, Robert
    Lamarche, Caroline
    Vallee, Michel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (10) : 895 - +
  • [35] Once-weekly intravenous paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients
    Staniforth, ME
    Cheng, SC
    Coyne, DW
    CLINICAL NEPHROLOGY, 2005, 63 (06) : 454 - 460
  • [36] Paricalcitol in the treatment of MHD with secondary hyperparathyroidism and bone pain
    Chen, Jingyi
    Cai, Liang
    Wen, Xiangqiong
    Xie, Xin
    Ou, Santao
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (05) : 1385 - 1388
  • [37] Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis
    Greenbaum, Larry A.
    Benador, Nadine
    Goldstein, Stuart L.
    Paredes, Ana
    Melnick, Joel Z.
    Mattingly, Susan
    Amdahl, Michael
    Williams, Laura A.
    Salusky, Isidro B.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (06) : 814 - 823
  • [38] Optimized dosing regimen of paricalcitol capsule for the treatment of secondary hyperparathyroidism in dialysis patients
    Ross, Edward
    Abboud, Hannah
    Tian, Jin
    Hippensteel, Richard
    Melnick, Joel
    Williams, Laura
    Hamm, L. Lee
    Sprague, Stuart
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 190 - 190
  • [39] Efficacy of alfacalcidol treatment for secondary hyperparathyroidism in patients with chronic renal failure before dialysis
    Rozhinskaya, L.
    Il'ina, A. N.
    Borisov, A. V.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S83 - S83
  • [40] Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism
    Akiba, T
    Marumo, F
    Owada, A
    Kurihara, S
    Inoue, A
    Chida, Y
    Ando, R
    Shinoda, T
    Ishida, Y
    Ohashi, Y
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (02) : 238 - 246
12345